Tuberculosis Drug Discovery: A Decade of Hit Assessment for Defined Targets
More than two decades have elapsed since the publication of the first genome sequence of Mycobacterium tuberculosis (Mtb) which, shortly thereafter, enabled methods to determine gene essentiality in the pathogen. Despite this, target-based approaches have not yielded drugs that have progressed to cl...
Main Authors: | Sangmi Oh, Lena Trifonov, Veena D. Yadav, Clifton E. Barry, Helena I. Boshoff |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-03-01
|
Series: | Frontiers in Cellular and Infection Microbiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcimb.2021.611304/full |
Similar Items
-
The Antitubercular Activities of Natural Products with Fused-Nitrogen-Containing Heterocycles
by: Helena I. Boshoff, et al.
Published: (2024-02-01) -
Primary Tuberculosis of the Chest Wall Without Pulmonary Involvement: A Case Report
by: Priyadarshini S. Nayak, et al.
Published: (2024-08-01) -
Primary nasal tuberculosis
by: Manoj Kumar Pandey, et al.
Published: (2020-01-01) -
Sputum Smear Non-conversion at the End of Intensive Phase of Tuberculosis Treatment at a Tertiary Center: A Descriptive Cross-sectional study
by: Naveen Prakash Shah, et al.
Published: (2021-11-01) -
Tuberculosis : laboratory diagnosis and treatment strategies /
by: McHugh, Timothy D. (Timothy Daniel)
Published: (c201)